Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Privia Health Group Inc (NASDAQ: PRVA) closed the day trading at $22.86 up 0.66% from the previous closing price of $22.71. In other words, the price has increased by $0.66 from its previous closing price. On the day, 0.65 million shares were traded. PRVA stock price reached its highest trading level at $23.1 during the session, while it also had its lowest trading level at $22.64.
Ratios:
For a better understanding of PRVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.60. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 1.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Mountcastle David sold 5,630 shares for $22.38 per share. The transaction valued at 125,999 led to the insider holds 179,676 shares of the business.
Mountcastle David bought 5,630 shares of PRVA for $126,001 on Apr 02 ’25. On Mar 12 ’25, another insider, Mehrotra Parth, who serves as the Chief Executive Officer of the company, sold 10,514 shares for $24.03 each. As a result, the insider received 252,651 and left with 469,381 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2872701952 and an Enterprise Value of 2317636352. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 199.83, and their Forward P/E ratio for the next fiscal year is 66.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.60 while its Price-to-Book (P/B) ratio in mrq is 4.33. Its current Enterprise Value per Revenue stands at 1.335 whereas that against EBITDA is 95.573.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.81, which has changed by 0.2581178 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.04, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is -4.01%, while the 200-Day Moving Average is calculated to be 9.46%.
Shares Statistics:
Over the past 3-months, PRVA traded about 831.20K shares per day on average, while over the past 10 days, PRVA traded about 827780 shares per day. A total of 120.31M shares are outstanding, with a floating share count of 107.44M. Insiders hold about 11.44% of the company’s shares, while institutions hold 95.32% stake in the company. Shares short for PRVA as of 1743379200 were 4168291 with a Short Ratio of 5.01, compared to 1740700800 on 4143718. Therefore, it implies a Short% of Shares Outstanding of 4168291 and a Short% of Float of 6.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
